![Robert Paproski](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profile
Robert Paproski is associated with Nanostics, Inc. as the Chief Technology Officer since 2017.
He is the founder of Nanostics, Inc. which was founded in 2017.
Robert Paproski active positions
Companies | Position | Start |
---|---|---|
Nanostics, Inc.
![]() Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | Founder | 2016-12-31 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 1 |
---|---|
Nanostics, Inc.
![]() Nanostics, Inc. Medical SpecialtiesHealth Technology Nanostics, Inc. specializes in the development and commercialization of novel, non-invasive diagnostic tests for cancer. It offers ClarityDx, is the accurate diagnostic test to diagnose aggressive prostate cancer, and is positioned to emerge as the diagnostic tool for prostate cancer. The company was founded by John Lewis, Catalina Vasquez, Desmond Pink and Robert Paproski in 2017 and is headquartered in Edmonton, Canada. | Health Technology |
- Stock Market
- Insiders
- Robert Paproski